ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,891, issued on June 16, was assigned to AVM Biotechnology LLC (Seattle).
"Stable glucocorticoid formulation" was invented by Theresa Deisher (Seattle), Adalbert Jarzyna (Seattle) and Iain Duncan (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to aqueous pharmaceutical formulations comprising a glucocorticoid. These have been formulated to contain high concentrations of glucocorticoid and reduced levels of preservatives."
The patent was filed on May 28, 2020, under Application No. 16/885,815.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PT...